Processa Pharmaceuticals, Inc. Balance Sheet
PCSA|6 years of annual SEC 10-K data (FY2013-FY2022)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
Processa Pharmaceuticals, Inc. had $9M in total assets and $25M in shareholders' equity as of FY2022.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2022 | FY2021 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.5M | $16.5M | $3.2K | $2.1K | $186.9K | $1.0M |
| Accounts Receivable | - | - | - | - | $4.1K | $19.2K |
| Inventory | - | - | - | - | $222.0K | $228.3K |
| Current Assets | $8.4M | $18.3M | $3.2K | $104.2K | $379.2K | $514.7K |
| PP&E (Net) | - | - | - | $159 | $466.4K | $369.8K |
| Total Assets | $8.6M | $26.5M | $3.2K | $104.3K | $2.5M | $2.9M |
| Current Liabilities | $998.6K | $971.0K | $2.4M | $2.1M | $840.1K | $1.1M |
| Shareholders' Equity | $25.5M | $22.9M | -$2.0M | -$2.0M | $1.2M | $1.7M |